Position in BIOA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$6,636,547
+$3,900,448 QoQ
Shares Held
270,769
+73.1% QoQ
Ownership
0.590%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#33
of 151 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BIOA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026GOLDMAN SACHS GROUP INC holds $1,964,785,401 across 53 Drug Manufacturers - Specialty & Generic names. BIOA ranks #31 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
3,199,799 | $229,937,554 | |
| 2 | VTRS |
Viatris Inc
|
13,564,872 | $215,410,166 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
6,129,240 | $207,658,650 | |
| 4 | HIMS |
Hims & Hers Health, Inc.
|
5,173,865 | $179,377,897 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
631,892 | $106,499,075 | |
| 6 | ALKS |
Alkermes plc.
|
2,023,984 | $106,056,760 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
814,096 | $90,315,809 | |
| 8 | UTHR |
UNITED THERAPEUTICS Corp
|
165,979 | $89,932,399 |
All Filings in BIOA
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,636,547 | 270,769 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $2,736,099 | 156,438 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $1,670,128 | 126,238 | Shares | Defined | 2026-03-25 | |
| 2025-09-30 | $527,306 | 89,678 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $102,390 | 24,792 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $100,613 | 26,759 | Shares | Defined | 2025-06-27 | |
| 2024-12-31 | $1,134,648 | 195,967 | Shares | Defined | 2025-02-11 | |
| 2024-09-30 | $2,259,212 | 108,616 | Shares | Defined | 2024-11-14 | |
| No filing history on record for this holder in this stock. | ||||||